Kedar Purushottam Phadke
No más puestos en curso
Perfil
Kedar Purushottam Phadke worked as a Secretary at Kirloskar Pneumatic Co. Ltd.
in 2009 and as a Secretary & Compliance Officer at Emcure Pharmaceuticals Ltd.
from 2010 to 2014.
He also worked as a Secretary & Compliance Officer at Thermax Ltd.
from 2017 to 2021.
Antiguos cargos conocidos de Kedar Purushottam Phadke.
| Empresas | Cargo | Fin |
|---|---|---|
| THERMAX LIMITED | Oficial de Cumplimiento | 19/08/2021 |
Emcure Pharmaceuticals Ltd.
 Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | Secretario Corporativo | - |
| KIRLOSKAR PNEUMATIC COMPANY LIMITED | Consejero General | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| KIRLOSKAR PNEUMATIC COMPANY LIMITED | Producer Manufacturing |
| THERMAX LIMITED | Producer Manufacturing |
| Empresas privadas | 1 |
|---|---|
Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | Health Technology |
- Bolsa de valores
- Insiders
- Kedar Purushottam Phadke
